Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-08 Purchase | 2024-04-10 4:35 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 2,600 | $13.57 | $35,290 | 62,936 (Direct) | View |
| 2024-03-28 Purchase | 2024-04-01 4:31 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 1,512 | $13.75 | $20,794 | 60,336 (Direct) | View |
| 2024-03-22 Purchase | 2024-03-26 5:57 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 9,048 | $13.58 | $122,882 | 58,824 (Direct) | View |
| 2024-03-19 Purchase | 2024-03-21 4:31 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 2,732 | $12.81 | $34,996 | 49,776 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 4:36 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,086 | $12.31 | $50,285 | 74,170 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 4:34 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 1,826 | $12.32 | $22,499 | 137,204 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 4:37 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,000 | $15 | $15,000 | 243,279 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:32 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,000 | $15.99 | $15,990 | 244,279 (Direct) | View |
| 2023-12-21 Sale | 2023-12-26 4:35 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $15.59 | $194,845 | 216,436 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 4:38 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $15 | $15,000 | 245,279 (Direct) | View |
| 2023-11-13 Sale | 2023-11-13 4:35 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $16.23 | $16,230 | 246,279 (Direct) | View |
| 2023-10-17 Sale | 2023-10-19 5:27 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $15 | $15,000 | 247,279 (Direct) | View |
| 2023-09-13 Sale | 2023-09-15 4:21 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $15 | $15,000 | 248,279 (Direct) | View |
| 2023-09-06 Sale | 2023-09-06 5:11 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 950 | $13.48 | $12,806 | 71,071 (Direct) | View |
| 2023-09-06 Sale | 2023-09-06 5:08 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 892 | $13.48 | $12,022 | 61,537 (Direct) | View |
| 2023-09-06 Sale | 2023-09-06 5:07 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 972 | $13.47 | $13,089 | 69,668 (Direct) | View |
| 2023-08-14 Sale | 2023-08-16 4:32 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $15.67 | $15,671 | 201,069 (Direct) | View |
| 2023-08-02 Sale | 2023-08-04 4:50 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 26,710 | $14.76 | $394,219 | 314,426 (Direct) | View |
| 2023-07-10 Sale | 2023-07-12 4:34 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 10,000 | $17.99 | $179,862 | 169,945 (Direct) | View |
| 2023-07-10 Sale | 2023-07-12 4:33 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 7,097 | $18.03 | $127,938 | 35,376 (Direct) | View |
| 2023-07-10 Sale | 2023-07-12 4:32 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 17,878 | $18.03 | $322,389 | 153,447 (Direct) | View |
| 2023-06-21 Sale | 2023-06-23 4:20 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 17,500 | $15.01 | $262,648 | 111,404 (Direct) | View |
| 2023-06-20 Sale | 2023-06-22 4:46 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 15,982 | $15.42 | $246,403 | 42,473 (Direct) | View |
| 2023-04-27 Sale | 2023-05-01 4:38 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 2,000 | $13.71 | $27,422 | 202,069 (Direct) | View |
| 2023-04-17 Sale | 2023-04-19 6:07 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 2,092 | $18.01 | $37,675 | 204,069 (Direct) | View |
| 2023-04-17 Sale | 2023-04-19 6:06 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 3,961 | $18 | $71,316 | 171,325 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $0 | 126,327 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $2.1 | 126,327 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:48 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 263,200 | $0 | 498,875 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 5,049 | $12.28 | 498,875 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,391 | $13.37 | 498,875 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,164 | $12.42 | 498,875 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:47 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 77,700 | $0 | 125,056 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,471 | $12.28 | 125,056 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 405 | $13.37 | 125,056 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 339 | $12.42 | 125,056 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:46 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 143,200 | $0 | 189,130 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 1,486 | $12.28 | 189,130 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 409 | $13.37 | 189,130 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 343 | $12.42 | 189,130 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:44 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 110,900 | $0 | 275,832 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,505 | $12.28 | 275,832 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 414 | $13.37 | 275,832 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 347 | $12.42 | 275,832 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-26 4:35 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $0 | 216,436 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-26 4:35 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $2.1 | 216,436 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:12 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 124,900 | $0 | 324,529 (Direct) | View |
| 2023-09-05 Tax Withholding | 2023-09-06 5:12 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,440 | $14.46 | 324,529 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:11 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 35,700 | $0 | 71,071 (Direct) | View |
| 2023-09-05 Tax Withholding | 2023-09-06 5:11 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 426 | $14.46 | 71,071 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:09 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 35,700 | $0 | 188,698 (Direct) | View |
| 2023-09-05 Tax Withholding | 2023-09-06 5:09 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 449 | $14.46 | 188,698 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:08 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 35,700 | $0 | 61,537 (Direct) | View |
| 2023-09-05 Tax Withholding | 2023-09-06 5:08 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 401 | $14.46 | 61,537 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:07 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 35,700 | $0 | 69,668 (Direct) | View |
| 2023-09-05 Tax Withholding | 2023-09-06 5:07 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 436 | $14.46 | 69,668 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-05 4:31 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Chapman Gina Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 4:50 pm | N/A 2030-12-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 26,710 | $0 | 314,426 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 4:50 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 26,710 | $2.1 | 314,426 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-12 4:34 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 10,000 | $0 | 169,945 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-12 4:34 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 10,000 | $2.1 | 169,945 (Direct) | View |
| 2023-06-29 Exercise | 2023-06-30 4:32 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 8,790 | $0 | 111,404 (Direct) | View |
| 2023-06-29 Exercise | 2023-06-30 4:32 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 8,790 | $2.1 | 111,404 (Direct) | View |
| 2023-06-21 Exercise | 2023-06-23 4:20 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 17,500 | $0 | 111,404 (Direct) | View |
| 2023-06-21 Exercise | 2023-06-23 4:20 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 17,500 | $2.1 | 111,404 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:06 pm | N/A 2033-06-08 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:06 pm | N/A 2033-06-08 | Entrada Therapeutics Inc. | TRDA | Thistle Mary Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:06 pm | N/A 2033-06-08 | Entrada Therapeutics Inc. | TRDA | Crowley John F Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:05 pm | N/A 2033-06-08 | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 16,000 | $0 | 16,000 (Direct) | View |